Sunday, June 26, 2022

Cardlytics Inc. (CDLX) may enjoy gains as insiders got busy in the recent days

Cardlytics Inc.’s filing revealed that its Director BALEN JOHN V acquired Company’s shares for reported $0.14 million on May 27. In the deal valued at $27.40 per share,5,000 shares were bought. As a result of this transaction, BALEN JOHN V now holds 41,798 shares worth roughly $ 1.08 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Then, BALEN JOHN V bought 2,000 shares, generating $59,198 in total proceeds. Upon buying the shares at $29.60, the Director now owns 35,097 shares.

Before that, Christiansen Andrew sold 250 shares. Cardlytics Inc. shares valued at $7,300 were divested by the Chief Financial Officer at a price of $29.20 per share. As a result of the transaction, Christiansen Andrew now holds 19,263 shares, worth roughly $0.5 million.

PT values the company’s stock at a premium of 64.19 to its Tuesday closing price. A number of analysts have revised their coverage, including Needham’s analysts, who began to cover the stock in mid June with a ‘”a Buy”‘ rating. Wells Fargo also remained covering CDLX and has increased its forecast on April 15, 2021 with a “an Overweight” recommendation from previously “an Equal weight” rating. Craig Hallum revised its rating on April 14, 2021. It rated CDLX as “a Buy” which previously was an “a Hold”.

Price Performance Review of CDLX

On Tuesday, Cardlytics Inc. [NASDAQ:CDLX] saw its stock jump 11.22% to $25.78. On the same session, the stock had its day’s lowest price of $23.3597, but rose to a high of $26.03. Over the last five days, the stock has gained 12.72%. Cardlytics Inc. shares have fallen nearly -60.99% since the year began. Nevertheless, the stocks have fallen -78.92% over the past one year. While a 52-week high of $134.91 was reached on 02/10/22, a 52-week low of $21.22 was recorded on 06/16/22. SMA at 50 days reached $32.66, while 200 days put it at $61.44. A total of 0.69 million shares were traded, compared to the trading of 0.32 million shares in the previous session.

Levels Of Support And Resistance For CDLX Stock

The 24-hour chart illustrates a support level at 24.08, which if violated will result in even more drops to 22.39. On the upside, there is a resistance level at 26.75. A further resistance level may holdings at 27.73. The Relative Strength Index (RSI) on the 14-day chart is 44.30, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.29, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 47.40%. Stochastics %K at 32.60% indicates the stock is a holding.

Cardlytics Inc. [CDLX] – Who Are The Largest Shareholders?

In filings from CAS Investment Partners LLC, it is revealed that the company now owns 5,416,116 shares, or roughly 15.88% of the outstanding CDLX shares. In other words, the investor’s shares have risen by 229,650 from its previous 13-F filing of 5186466.0. Additionally, Wellington Management Co. LLP decreased -4.77% of its stake after which the total value it holdings stand at $94,948,205, while The Vanguard Group, Inc. added 0.94% of its stake to hold $73.62 million in the firm. Over the last quarter, BlackRock Fund Advisors sold -17,754 shares of Cardlytics Inc., while 683 Capital Management LLC sold 53,778 shares. At present, Alua Capital Management LP is holding 1,338,359 shares valued at $34.68 million. JPMorgan Investment Management, I owned 1,337,489 shares of the company at the time of its most recent 13F filing, worth $34.65 million.

According to FactSet, Cardlytics Inc.’s share price will average $57.00 in the next year, based on opinions of analysts polled by the firm. This is up nearly 141.59 percent from its previous closing price of $23.18. Analysts expect Cardlytics Inc. stock to reach the higher price of $72.00, while the lowest price estimate is $47.00. However, 6 analysts have rated CDLX stock as an Overweight in their predictions for 2022.

Latest news

Related news


Please enter your comment!
Please enter your name here




Download Free eBook For

The 5 Best Growth Stocks 2022

100% free. stop anytime no spam